摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2'',5',6''-tri-O-benzyl-3'-O-α-D-glucopyranosyl-1-β-D-ribofuranosidoimidazole | 308290-85-9

中文名称
——
中文别名
——
英文名称
2'',5',6''-tri-O-benzyl-3'-O-α-D-glucopyranosyl-1-β-D-ribofuranosidoimidazole
英文别名
Bn(-2)[Bn(-6)]Glc(a1-3)[Bn(-5)]Ribf(b)-imidazol-1-yl;(2R,3S,4S,5R,6R)-6-[(2R,3S,4R,5R)-4-hydroxy-5-imidazol-1-yl-2-(phenylmethoxymethyl)oxolan-3-yl]oxy-5-phenylmethoxy-2-(phenylmethoxymethyl)oxane-3,4-diol
2'',5',6''-tri-O-benzyl-3'-O-α-D-glucopyranosyl-1-β-D-ribofuranosidoimidazole化学式
CAS
308290-85-9
化学式
C35H40N2O9
mdl
——
分子量
632.711
InChiKey
WCFZSALIPCZXFM-APZXYDBQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    46
  • 可旋转键数:
    14
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    134
  • 氢给体数:
    3
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Convergent synthesis of adenophostin A analogues via a base replacement strategy
    作者:Rachel D. Marwood、Satoshi Shuto、David J. Jenkins、Barry V. L. Potter
    DOI:10.1039/a909347h
    日期:——
    The first totally synthetic base-modified analogues of the natural product and potent D-myo-inositol 1,4,5-trisphosphate receptor agonist adenophostin A were efficiently synthesised from D-xylose and D-glucose using methodology employing base and surrogate base addition to a common disaccharide intermediate.
    天然产物的第一个完全合成的碱基修饰类似物和有效的 D-肌醇 1,4,5-三磷酸受体激动剂腺苷 A 是由 D-木糖和 D-葡萄糖使用碱基和替代碱基添加的方法有效合成的一种常见的二糖中间体。
  • Contribution of the Adenine Base to the Activity of Adenophostin A Investigated Using a Base Replacement Strategy
    作者:Rachel D. Marwood、David J. Jenkins、Vanessa Correa、Colin W. Taylor、Barry V. L. Potter
    DOI:10.1021/jm000265o
    日期:2000.11.1
    pha-D-glucopyranosyl-D-ribofuranose. Vorbrüggen condensation with activated imidazole or purine gave the required beta-substituted derivatives which were further elaborated to 7 and 8, respectively. Radioligand binding assays to hepatic InsP(3) receptors and functional assays of Ca(2+) release from permeabilized hepatocytes gave a rank order of potency of the ligands 2 approximately 8 > 7 approximately
    3'-O-α-D-吡喃葡萄糖基-1-β-D-呋喃呋喃糖基氨基咪唑2',3'',4''-三磷酸(7)和3'-O-α-D-吡喃葡萄糖基-9-beta的合成描述了-D-呋喃呋喃核糖嘌呤2',3'',4''-三磷酸(8),这是超强1D-肌醇1,4,5-三磷酸受体激动剂腺苷A(2)的两个类似物。通过改进的路线由1,2-O-异亚丙基-α-D-木呋喃糖制备5-O-苄基-1,2-O-异亚丙基-α-D-呋喃核糖,并与3,4-di-O偶联-乙酰基-2,6-二-O-苄基-D-吡喃葡萄糖基二甲基亚磷酸酯得到3',4'-二-O-乙酰基-2',5,6'-三-O-苄基-3-O- α-D-吡喃葡萄糖基-1,2-O-异亚丙基-α-D-呋喃呋喃糖。除去异亚丙基缩醛并随后乙酰化得到中心二糖1,2,3',4'-四-O-乙酰基-2',5、6'-三-O-苄基-3-O-α-D-吡喃葡萄糖基-D-呋喃呋喃糖。用活化的咪唑或嘌呤进行弗布吕
查看更多

同类化合物

阿卡地新 咪唑立宾 5'-单磷酸酯 咪唑立宾 [(2R,3S,4R,5R)-5-[4-氨基甲酰-5-[[(3R,4R)-3,4-二羟基-2-氧代-5-膦酰氧基戊基]亚氨基甲基氨基]咪唑-1-基]-3,4-二羟基四氢呋喃-2-基]磷酸二氢甲酯 N-[5-氨基-1-(BETA-D-呋喃核糖基)咪唑-4-羰基]-L-天冬氨酸 5-碘-1-(2’,3’,5’-三-O-乙酰基-beta-D-呋喃核糖基)-咪唑并-4-甲腈 5-甲酰氨基咪唑-4-甲酰胺核苷酸 5-氯-1-[3,4-二羟基-5-(羟基甲基)四氢呋喃-2-基]咪唑-4-甲酰胺 5-氨基-4-咪唑甲酰胺核糖甙 5'-三磷酸酯 5-氨基-1-(2-O,3-O,5-O-三乙酰基-beta-D-呋喃核糖基)-1H-咪唑-4-甲酰胺 5-氨基-1-(2,7-二羟基-2-氧代四氢-4H-呋喃并[3,2-d][1,3,2]二氧杂环己膦烷-6-基)-1H-咪唑-4-甲酰胺 5-乙炔基-1-呋喃核糖基咪唑-4-甲酰胺 4-(羧甲基)-1-(beta-D-呋喃核糖基)-1H-咪唑 2-硝基-1-beta-D-呋喃核糖基-1H-咪唑 1-alpha-D-阿拉伯呋喃糖基-2-硝基-1H-咪唑 1-(alpha-D-阿拉伯呋喃糖基)-1H-咪唑-2-胺 (2S)-2-[[5-氨基-1-[(2R,3R,4S,5R)-3,4-二羟基-5-(膦酰氧基甲基)四氢呋喃-2-基]咪唑-4-羰基]氨基]丁二酸 (2R)-2-环己基-2-羟基-2-苯基乙酸 (1-羟基乙基)-5-甲基-1-beta-呋喃核糖基咪唑 5-amino-1-(β-D-ribofuranosyl)-4-(5-propyl-1,2,4-oxadiazol-3-yl)imidazole 5-amino-1-(β-D-ribofuranosyl)-4-(5-phenyl-1,2,4-oxadiazol-3-yl)imidazole 5-amino-1-(β-D-ribofuranosyl)-4-[5-(1-methylethyl)-1,2,4-oxadiazol-3-yl]imidazole 5-amino-1-(β-D-ribofuranosyl)-4-(5-ethyl-1,2,4-oxadiazol-3-yl)imidazole 5-amino-1-(β-D-ribofuranosyl)-4-[5-(1,1-dimethylethyl)-1,2,4-oxadiazol-3-yl]imidazole 5-[1-(Dimethylamino)ethylideneamino]-1-[2,3-O-(1-methylethylidene)-β-D-ribofuranosyl]-imidazole-4-carbonitrile 1-(2',3',5'-tri-O-benzoyl-β-D-ribofuranosyl)-4-(3-ureidophenyl)imidazole 5-amino-2-(4-fluorophenyl)-1-β-D-ribofuranosylimidazole-4-carboxamide 5-amino-2-(3-chlorophenyl)-1-β-D-ribofuranosylimidazole-4-carboxamide 5-amino-2-(4-methoxyphenyl)-1-β-D-ribofuranosylimidazole-4-carboxamide 5-amino-2-(2-phenylvinyl)-1-β-D-ribofuranosylimidazole-4-carboxamide 5-amino-2-phenyl-1-β-D-ribofuranosylimidazole-4-carboxamide 5-amino-2-(2-furyl)-1-β-D-ribofuranosylimidazole-4-carboxamide 5-amino-1-β-D-ribofuranosylimidazole-2-(2-thienyl)-4-carboxamide 5-amino-1-β-D-ribofuranosylimidazole-4-carboxamideoxime hydrochloride acadesine-5’-O-bis(benzoxy-L-alaninyl)phosphate 5-diazonium-1-β-D-ribofuranosyl-1H-imidazole-4-carboxamide 5-amino-1-(3-O-methyl-β-D-ribofuranosyl)imidazole-4-carboxamide 5-amino-1-(3-O-n-butyl-β-D-ribofuranosyl) imidazole-4-carboxamide 5-amino-1-(3-O-ethyl-β-D-ribofuranosyl)-4-imidazole carboxamide 5-amino-1-(2-O-ethyl-β-D-ribofuranosyl)-4-imidazole carboxamide N4-(benzyl) AICAR triphosphate N1-<(β-D-Ribosyl)formimino>-5-aminoimidazole-4-carboxamide ribonucleotide N1-<(5''-Phospho-β-D-ribosyl)formimino>-5-aminoimidazole-4-carboxamide ribonucleoside N1-<(β-D-Ribosyl)formimino>-5-aminoimidazole-4-carboxamide ribonucleoside 2-Benzyl-1-(β-D-ribofuranosyl)imidazol-4,5-dicarboxamid 4-N-[(S)-pyrrolidine-2-carbonyl]amino-1-β-D-ribofuranosylimidazole 5-amino-1-(β-D-ribofuranosyl)-4-(5-pentyl-1,2,4-oxadiazol-3-yl)imidazole 5-amino-1-(β-D-ribofuranosyl)-4-(5-heptyl-1,2,4-oxadiazol-3-yl)imidazole acadesine-5’-O-bis(methoxy-L-alaninyl)phosphate 4,5-dichloro-1-(β-D-ribofuranosyl)imidazole